Abstract
Radioiodine whole-body scintigraphy has long been used for detection of differentiated thyroid carcinoma with high avidity in functioning thyroid tissues. However, uptake is not completely specific, and "false-positive"uptake in nonthyroidal tumors have rarely been reported. Herein, we present a case of incidentally detected neuroendocrine tumor showing high radioiodine uptake initially suspected to be thyroid metastasis. Correlative imaging with FDG PET/CT and 68Ga-DOTATATE PET/CT is presented, and literature survey is discussed. We conclude that neuroendocrine tumor should be added to the reported list of neoplasms that can show "false-positive"uptake representing a potential interpretative pitfall.
| Original language | English |
|---|---|
| Pages (from-to) | E643-E646 |
| Journal | Clinical Nuclear Medicine |
| Volume | 47 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Oct 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- FDG PET/CT
- Ga-DOTATATE PET/CT
- differentiated thyroid carcinoma
- false-positive uptake
- neuroendocrine tumor
- radioiodine I whole-body scintigraphy
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Radioiodine Uptake in Incidentally Detected Neuroendocrine Tumor: Correlative Imaging with FDG PET/CT and 68Ga-DOTATATE PET/CT'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver